SCOPUS 정보 검색 플랫폼

Volumn 71, Issue 3, 2001, Pages 280-288

Biopharmaceutical considerations of dissolution testing used as a prognostic tool for oral drug absorption;A hatóanyag orális felszívódásának elorejelzésére alkalmazott kioldódás vizsgálatok biofarmáciai vonatkozásai

(1) Antal, István a

a SEMMELWEIS UNIVERSITY (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CARBAMAZEPINE; CIMETIDINE; FUROSEMIDE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; KETOCONAZOLE; METOPROLOL; PARACETAMOL; RANITIDINE; THEOPHYLLINE;

DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; FOOD INTAKE; GASTROINTESTINAL TRACT; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; PROGNOSIS; QUALITY CONTROL; REVIEW;

ADMINISTRATION, ORAL; HUMANS; INTESTINAL ABSORPTION; PHARMACEUTICAL PREPARATIONS; PROGNOSIS; SOLUTIONS;

EID: 0035709866 PISSN: 00016659 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (12)

References (61)

1
- 0003701605
- Center for Drug Evaluation and Research, Food and Drug Administration, September
- (1997) Extended Release Solid Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations

2
- 0030017609
- (1996) J. Pharm. Sci. , vol.85 , pp. 753-760
- Polli, J.E.¹ Crison, J.R.² Amidon, G.L.³

3
- 0031750861
- (1998) Pharm. Res. , vol.15 , pp. 698-705
- Galia, E.¹ Nicolaides, E.² Horter, D.³ Lobenberg, R.⁴ Reppas, C.⁵ Dressman, J.B.⁶

4
- 2042418322
- Committee for Proprietary Medicinal Products, 155/96, EMEA
- Note for Guidance on Development Pharmaceutics

5
- 0003419264
- Committee for Proprietary Medicinal Products, 1401/98, EMEA
- Note for Guidance on the Investigation of Bioavailability and Bioequivalence

6
- 0003419283
- Directive 65/65/EEC, Annex to Directive 75/318/EEC, December
- (1991) Note for Guidance: Investigation of Bioavailability and Bioequivalence

7
- 2042527816
- Annex to Directive 75/318/EEC, July
- (1990) Note for Guidance: Clinical Testing of Prolonged Action Forms with Special Reference to Extended Release Forms

8
- 2042516011
- Theory of dosage forms dissolution
- (1982) Proc. 2nd Wisconsin Update Conference-Dissolution-State of the Art
- Carstensen, J.¹

9
- 0027463079
- Modelling of dissolution behaviour of controlled release systems
- (1993) STP Pharma Pratiques , vol.3 , Issue.1 , pp. 49-58
- Makoid, M.C.¹ Dufour, A.² Banakar, U.V.³

10
- 4243436011
- Gyógyszertechnológia I-III
- Budapest
- (2001) Medicina Könyvkiadö
- Rácz-Selmeczi¹

11
- 0003570307
- Wissenschaft. Verlagsges. mbH, Stuttgart
- (1991) Controlled/Modified Release Products
- Blume, H.¹ Gunder-Remy, U.² Möller, H.³

12
- 0030573064
- (1996) Int. J. Pharm. , vol.145 , pp. 61-64
- Dredán, J.¹ Antal, I.² Rácz, I.³

13
- 0034058121
- (2000) Pharm. Res. , vol.17 , pp. 108-112
- Macheras, P.¹ Dokoumetzidis, A.²

14
- 0345551958
- (1999) Pharm. Dev. Technol. , vol.4 , Issue.2 , pp. 291-294
- Csóka, G.¹ Dredán, J.² Marton, S.³ Antal, I.⁴ Rácz, I.⁵

15
- 0348101381
- Committee for Proprietary Medicinal Products, 604/96, EMEA, July
- (1999) Note for Guidance on Quality of Modified Released Products

16
- 2042527816
- Annex to Directive 75/318/EEC, July
- (1990) Note for Guidance: Clinical Testing of Prolonged Action Forms with Special Reference to Extended Release Forms

17
- 0003455057
- FDA, Center for Drug Evaluation and Research August
- (2000) Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System

18
- 2042457746
- (1997) Ph.Eur. 3rd. Ed.

19
- 0003428587
- FDA, Center for Drug Evaluation and Research, September
- (1997) Guidance for Industry, SUPAC-MR: Modified Release Solid Oral Dosage Forms

20
- 2042434700
- Standard terms: Pharmaceutical dosage forms
- January
- (2000) Pharmeuropa , Issue.SPEC. ISSUE

21
- 2042424875
- Annex to Directive 75/318/EEC, October
- (1992) Note for Guidance: Quality of Prolonged Release Oral Solid Dosage Forms

22
- 2042432992
- (2000) Ph.Eur. 3rd. Ed. , Issue.SUPPL. , pp. 1357

23
- 0031913402
- (1998) Pharm. Res. , vol.15 , pp. 11-22
- Dressman, J.B.¹ Amidon, G.L.² Reppas, C.³ Shah, V.P.⁴

24
- 0008385753
- (1969) Pharm. Ind. , vol.31 , pp. 794
- Stricker, H.¹

25
- 2042453474
- (1971) Pharm. Ind. , vol.33 , Issue.157 , pp. 446
- Stricker, H.¹

26
- 0019487675
- (1981) J. Pharm. Sci. , vol.70 , pp. 1017
- Yau, M.K.T.¹ Meyer, M.C.²

27
- 0020660928
- (1983) Arzneim.-Forsch./Dug Res. , vol.33 , Issue.1 , pp. 598-601
- Brockmeier, D.¹ Voegele, D.² Hattingberg, H.M.³

28
- 4243495303
- (1986) Gyógyszerészet , vol.30 , pp. 289-294
- Szentmiklósi, P.¹ Marton, S.² Hajdú, M.³

29
- 0028948839
- (1995) Pharm. Res. , vol.12 , pp. 413-420
- Amidon, G.L.¹ Lennernas, H.² Shah, V.P.³ Crison, J.R.⁴

30
- 0004037003
- McGraw, Hill MPD
- (1999) Applied Biopharmaceutics and Pharmacokinetics. 4th Ed.
- Shargel, L.¹ Yu, A.²

31
- 0021359386
- (1984) Pharm. Ind. , vol.46 , pp. 88
- Gröning, V.R.¹

32
- 0022618014
- (1986) J. Pharm. Sci. , vol.75 , pp. 109-116
- Dressmann, J.B.¹ Fleisher, D.²

33
- 0034916430
- (2001) Pharm. Tech. , vol.6 , pp. 68-76
- Dressman, J.B.¹ Butler, J.² Hempenstall, J.³ Reppas, C.⁴

34
- 0026795241
- (1992) Pharm. Res. , vol.9 , pp. 1243-1255
- Lennernas, H.¹

35
- 0003428585
- FDA, Center for Drug Evaluation and Research, August
- (1997) Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms

36
- 0030793250
- (1997) Adv. Exp. Med. Biol. , vol.423 , pp. 111-128
- Corrigan, O.I.¹

37
- 0034595304
- (2000) Eur. J. Pharm. Biopharm. , vol.49 , Issue.3 , pp. 225-229
- Grattan, T.¹

38
- 0028805172
- (1995) J. Pharm. Sci. , vol.84 , Issue.12 , pp. 1405-1409
- Adkin, D.A.¹

39
- 33947487639
- (1897) J. Amer. Chem. Soc. , vol.19 , pp. 930-934
- Noyes, A.A.¹ Whitney, W.R.²

40
- 0002642747
- (1904) Z. Physik Chem. , vol.47 , pp. 52-110
- Nernst, W.¹ Brunner, E.²

41
- 84993708213
- FIP guidelines for dissolution. Testing of solid oral products
- (1996) Drug Inf. J. , vol.30 , pp. 1071-1084

42
- 23544458543
- Akadémiai Kiadó, Budapest
- (1973) Szerves vegyületek krisztallográfiai vizsgálata
- Nikolics, K.¹

43
- 4243688756
- (2000) Eur. J. Pharm. Sci. , vol.12
- Dressmann, J.B.¹ Reppas, C.²

44
- 0025030536
- (1990) Pharm. Res. , vol.7 , pp. 756-761
- Dressmann, J.B.¹

45
- 33845222050
- (1996) Pharmacopeial Forum , vol.22 , pp. 1943-1945
- Gray, V.¹ Dressmann, J.B.²

46
- 2042532792
- Editions de Sante, Paris
- (1996) Formulation of PoorlyAvailable Drugs for Oral Administration (Minutes of the European Symposium)
- Uch, A.S.¹ Dressmann, J.B.²

47
- 0026574779
- (1992) Pharm. Res. , vol.9 , pp. 1540-1545
- Bronsted, H.¹ Kopecek, J.²

48
- 0013932518
- (1966) Amer. J. Dig. Dis. , vol.11 , pp. 503-521
- Fordtran, J.S.¹ Lochlear, T.²

49
- 0001419666
- FIP guidelines for dissolution testing of solid oral products
- (1981) Pharm. Ind. , vol.43 , pp. 334-343

50
- 2042457745
- USP
- (1995) 〈1088〉 In vitro and in vivo evaluation of dosage forms , vol.23

51
- 0011280557
- (1999) Pharm. Res. , vol.16 , pp. 272-280
- Kaus, L.C.¹ Gillespie, W.R.² Hussain, A.S.³ Amidon, G.A.⁴

52
- 0019378035
- (1981) Dig. Dis. Sci. , vol.26 , pp. 16-22
- Moore, J.G.¹ Chistian, P.E.² Coleman, R.E.³

53
- 0023934540
- (1988) Gastroenterology , vol.94 , pp. 1315-1325
- Meyer, J.H.¹ Elashoff, J.² Porter-Fink, V.³ Dressmann, J.B.⁴ Amidon, G.L.⁵

54
- 0020540487
- (1983) Gastroenterology , vol.85 , pp. 76-82
- Brener, W.¹ Hendrix, T.R.² McHugh, P.R.³

55
- 0020040813
- (1982) Gastrenterology , vol.83 , pp. 701-706
- Kerlin, P.¹ Zinsmeister, A.² Phillips, S.³

56
- 0001370474
- (1930) Amer. J. Physiol. , vol.92 , pp. 466-497
- Hoelzel, F.¹

57
- 0022350057
- (1985) Brit. J. Clin. Pharmacol. , vol.19
- John, V.A.¹ Shotton, P.A.² Moppert, J.³ Theobold, W.⁴

58
- 0021682974
- (1984) Gastroenterology , vol.87 , pp. 1255-1263
- Malagelada, J.R.¹

59
- 0022538998
- (1986) Gut , vol.27 , pp. 886-892
- Davis, S.S.¹ Hardy, J.G.² Fara, J.W.³

60
- 85044685135
- (1976) Gut , vol.17 , pp. 1007-1011
- Wiggins, H.S.¹ Cummings, J.H.²

61
- 0003653628
- Chapter 6, Ellis Harwood Series in Pharmaceutical Technology, Chichester, UK
- (1989) Physiological Pharmaceutics-Biological Barriers to Drug Absorption
- Wilson, C.G.¹ Washington, N.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.